search
Back to results

The Diagnostic Validity of the Urea Breath Test

Primary Purpose

Helicobacter Pylori Infection

Status
Completed
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Citric acid
Sponsored by
Seoul National University Bundang Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Helicobacter Pylori Infection focused on measuring Helicobacter pylori infection, Eradication, Urea breath test

Eligibility Criteria

18 Years - 90 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Male and female Korean adult (Aged over 18 years)
  • The Patients who diagnosed H. pylori infection and received H. pylori eradication therapy

Exclusion Criteria:

  • Age under 18 years
  • Patients who took any drug which could affect the study results such as proton pump inhibitor, H2 blocker, mucosal protective agents and antibiotics
  • Advanced gastric cancer or other malignancy
  • Abnormal liver function test or liver cirrhosis
  • Abnormal renal function or chronic kidney disease
  • Other severe concurrent disease

Sites / Locations

  • Seoul National University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Citric acid group

Controlled group

Arm Description

Giving the citric acid (4g) as test meal before UBT

No use of test meal

Outcomes

Primary Outcome Measures

Number of participants who showed discrepant result between UBT result and endoscopic result in both citric acid group and controlled group
After urea breath test in the two group (citric acid group vs controlled group), endoscopic surveillance would be performed for confirmation of H. pylori status by endoscopic biopsy methods(histology, CLOtest or culture).
Compare the diagnostic accuracy which is a composite outcome measure such as sensitivity, specificity, predictive positive value and negative predictive value between citric acid group and controlled group
Comparing the final H. pylori status between UBT method and endoscopic biopsy methods, we will evaluate the diagnostic accuracy (sensitivity, specificity, false positive ratio, false negative ratio, positive predictive value and negative predictive value) of the UBT between using citric acid group and controlled group.

Secondary Outcome Measures

Full Information

First Posted
January 18, 2015
Last Updated
April 17, 2019
Sponsor
Seoul National University Bundang Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT02359942
Brief Title
The Diagnostic Validity of the Urea Breath Test
Official Title
The Effect of Citric Acid as the Test Meal on the Diagnostic Accuracy of the 13C-Urea Breath Test in Korean, Randomized Controlled, Open Label Prospective Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
March 1, 2015 (Actual)
Primary Completion Date
December 31, 2018 (Actual)
Study Completion Date
December 31, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Bundang Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
To compare the diagnostic accuracy of the 13C-Urea breath test between using the citric acid as test meal and controlled group by endoscopic biopsy methods(histology, CLOtest and H. pylori culture). To compare the delta value of 13CO2 results between before and after ingestion of citric acid as test meal.
Detailed Description
1-1 Screening (visit 1, From -6 to -8 weeks) and H. pylori eradication To accept the agreement, confirm inclusion/exclusion criteria, and evaluate the baseline characteristics of patients H. pylori eradication First eradication: PPI-based triple therapy (standard dose of PPI b.i.d., clarithromycin 500 mg b.i.d., and amoxicillin 1 g b.i.d. for 1 week), and sequential therapy (initial 5-day therapy with a combination of PPI b.i.d and amoxicillin 1g b.i.d, followed by 5 days of PPI b.i.d., clarithromycin 500mg b.i.d., and metronidazole 500mg t.i.d) Rescue therapy: bismuth-containing quadruple therapy [PPI b.i.d., tripotassium dicitrate bismuthate 300 mg q.i.d. (three tablets at 30 min before meals and one tablet at 2 hours after dinner), metronidazole 500 mg t.i.d., and tetracycline 500 mg q.i.d.] for 1-2 weeks, or moxifloxacin-containing triple therapy (moxifloxacin 400 mg q.d., amoxicillin 1g b.i.d., and PPI b.i.d.) for 1-2 weeks. 1-2 Baseline (visit 2, 0 week): urea breath test Reconfirm inclusion and exclusion criteria Randomization for UBT test (citric acid group vs control group) In citric acid group: taking 4 g of citric acid solving in 200 ml of water 10 minutes before UBT. Perform UBT in both group 1-3) Endoscopic surveillance (visit 3, 6 or later months) Endoscopic surveillance for final H. pylori status after UBT Histology, CLOtest or H. pylori culture Statical analysis for diagnostic accuracy of the UBT between citric acid group and controlled group: sensitivity, specificity, positive predictive value, negative predictive value, false positive rate, and false negative rate. 2. Selecting 40 patients who showed UBT result between 2.5 to 4.0 in controlled group, the investigators are planning to reperform 13C-UBT after giving citric acid as test meal. And then, the investigators compare the change of UBT result before and after ingestion citric acid as test meal.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Helicobacter Pylori Infection
Keywords
Helicobacter pylori infection, Eradication, Urea breath test

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Allocation
Randomized
Enrollment
1200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Citric acid group
Arm Type
Experimental
Arm Description
Giving the citric acid (4g) as test meal before UBT
Arm Title
Controlled group
Arm Type
No Intervention
Arm Description
No use of test meal
Intervention Type
Drug
Intervention Name(s)
Citric acid
Intervention Description
Giving the citric acid (4g) solving in 200 ml of water before UBT
Primary Outcome Measure Information:
Title
Number of participants who showed discrepant result between UBT result and endoscopic result in both citric acid group and controlled group
Description
After urea breath test in the two group (citric acid group vs controlled group), endoscopic surveillance would be performed for confirmation of H. pylori status by endoscopic biopsy methods(histology, CLOtest or culture).
Time Frame
6 months or later after urea breath test
Title
Compare the diagnostic accuracy which is a composite outcome measure such as sensitivity, specificity, predictive positive value and negative predictive value between citric acid group and controlled group
Description
Comparing the final H. pylori status between UBT method and endoscopic biopsy methods, we will evaluate the diagnostic accuracy (sensitivity, specificity, false positive ratio, false negative ratio, positive predictive value and negative predictive value) of the UBT between using citric acid group and controlled group.
Time Frame
6 months or later after urea breath test

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Male and female Korean adult (Aged over 18 years) The Patients who diagnosed H. pylori infection and received H. pylori eradication therapy Exclusion Criteria: Age under 18 years Patients who took any drug which could affect the study results such as proton pump inhibitor, H2 blocker, mucosal protective agents and antibiotics Advanced gastric cancer or other malignancy Abnormal liver function test or liver cirrhosis Abnormal renal function or chronic kidney disease Other severe concurrent disease
Facility Information:
Facility Name
Seoul National University Hospital
City
Seongnam
Country
Korea, Republic of

12. IPD Sharing Statement

Learn more about this trial

The Diagnostic Validity of the Urea Breath Test

We'll reach out to this number within 24 hrs